Medical Sciences Forum

Journal Browser

► Journal Browser

Med. Sci. Forum, 2026, FIT Cancer 12

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.

You may sign up for e-mail alerts to receive table of contents of newly released issues.

PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Cover Story (view full-size image): The XII Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 12), organized by the Spanish Group for Cancer Immuno-Biotherapies (GÉTICA), took place on 5–6 March 2026 [...] Read more.

15 pages, 6634 KB

Open AccessConference Report

Abstracts of the XII Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 12)

by Rodolfo Chicas-Sett, Luis de la Cruz, Delvys Rodríguez-Abreu, Luis Álvarez-Vallina, Manel Juan, Elisabeth Pérez-Ruiz, Xabier Mielgo, Francisco Aya and Ana Arance

Med. Sci. Forum 2026, 50(1), 1; https://doi.org/10.3390/msf2026050001 - 3 Sep 2026

Viewed by 205

Abstract

The XII Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 12), organized by the Spanish Group for Cancer Immuno-Biotherapies (GÉTICA), took place on 5–6 March 2026 in Málaga, Spain. This edition gathered clinicians, basic scientists, and translational researchers from Spain and international institutions to discuss the latest advances in cancer immunotherapy. Scientific contributions spanned a wide range of topics, including engineered T-cell therapies targeting solid tumors and hematological malignancies, neoantigen-based cancer vaccines in preventive and therapeutic settings, oncolytic virotherapy combined with immune cell recruitment strategies, metabolic reprogramming of the tumor microenvironment, epigenetic liquid biopsy biomarkers, and the management of immune-related adverse events in clinical practice. The abstracts presented here reflect the breadth and translational depth of immuno-oncology research currently underway within the GÉTICA network and its international collaborators. Full article

(This article belongs to the Proceedings of XII Forum on Translational Immunology and Cancer Immunotherapy)

► Show Figures

Figure 1

Journal Menu

Journal Browser

Med. Sci. Forum, 2026, FIT Cancer 12

XII Forum on Translational Immunology and Cancer Immunotherapy

Other

Further Information

Guidelines

MDPI Initiatives

Follow MDPI